Skip to content

Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland

Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07109141
Acronym
PFA Registry
Enrollment
500
Registered
2025-08-07
Start date
2024-08-01
Completion date
2030-07-01
Last updated
2025-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ablation Techniques, Atrial Fibrillation (AF), Atrial Flutter, Atrial Tachycardia, Pulsed Field Ablation

Brief summary

The aim of the described project is to establish a multicenter, nationwide registry of atrial arrhythmia ablation procedures using the Pulsed Field Ablation (PFA) method. These procedures have only recently begun to be performed in several centers across Poland. With proper coordination of the registry, this will enable the consolidation of clinical data and the expansion of knowledge regarding the efficacy and safety of these procedures.

Detailed description

Background A relatively recent innovation in cardiac ablation is Pulsed Field Ablation (PFA), a technique based on the phenomenon of irreversible electroporation. This method is tissue-selective, affecting only myocardial cells. Clinical studies have confirmed the efficacy and safety of PFA in the treatment of paroxysmal atrial fibrillation (AF). Although the catheters currently used for PFA are designed primarily for pulmonary vein isolation (PVI) in AF ablation, there are growing numbers of reports describing their successful application in the ablation of other arrhythmias-such as atrial flutter, atrial tachycardia, and even ventricular tachycardia. However, the efficacy of such procedures has not yet been systematically evaluated in experimental or clinical settings. We believe that establishing a national registry documenting PFA procedures for atrial arrhythmias will provide valuable insights into the clinical efficacy, safety, and procedural techniques of this emerging treatment strategy. Furthermore, it will support the planning and design of future randomized clinical trials in this area. Objectives The aim of the project is to establish a multicenter, nationwide registry of PFA-based ablation procedures for arrhythmias other than atrial fibrillation. Study Design and Planned Procedures The project involves the collection of clinically relevant data from patients undergoing PFA procedures targeting arrhythmias outside the pulmonary veins. Participation in the registry will not require any additional procedures during hospitalization beyond standard clinical care. Patients will be followed for 12 months post-ablation. Follow-up will include telephone interviews conducted at 3, 6, and 12 months after the procedure. If necessary, based on the telephone assessment, patients may be invited for an in-person clinical evaluation at the center where the procedure was performed. The registry will be coordinated by the Institute for Heart Diseases at the Jan Mikulicz-Radecki University Hospital in Wroclaw, Poland. Other hospitals in Poland performing PFA procedures will be invited to participate in the registry.

Interventions

PROCEDUREPFA ablation procedure of atrial arrythmia

PFA ablation procedure of atrial arrythmia accroding to the particular patients needs

Sponsors

Wroclaw Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed consent obtained from the participant * Subject is undergoing ablation of an atrial arrhythmia using the PFA

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Recurrence of supraventricular arrhythmia12 monthsRecurrence of any supraventricular arrhythmia recorded in the ECG and provided by the participant.

Countries

Poland

Contacts

Primary ContactStanislaw Tubek, MD, PhD
stanislaw.tubek@umw.edu.pl+48 71 733 11 12

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026